Effect of Atazanavir on Endothelial Function in HIV-Infected Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

May 31, 2006

Conditions
HIV InfectionsDyslipidemia
Interventions
DRUG

ATAZANAVIR

Trial Locations (1)

8091

University Hospital Zurich, Infectiology, Zurich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Foundation for Cardiovascular Research, Zurich

OTHER